54606-68-7

Upstream product

• 54606-67-6 allyl-2,3,4-tri-O-benzyl-6-O-trityl-D-glucopyranoside 
• 100-39-0 benzyl bromide 

Downstream Products

• 193953-70-7 C₃₁H₄₁N₂O₇P 
• 193953-66-1 C₆₅H₇₅N₂O₁₂P 
• 156199-22-3 2,3,4-tri-O-benzyl-6-O-(2,2,2-trichloroethoxycarbonyl)-D-glucopyranosyl fluoride 
• 1210344-30-1 (3R,4S,5S)-3,4,5-tris-benzyloxy-6,6-bis-(4-methoxybenzyloxymethyl)tetrahydropyran-2-one 
• 1210344-28-7 (3S,4S,5R)-6-allyloxy-3,4,5-tris-benzyloxy-2,2-bis(4-methoxybenzyloxymethyl)tetrahydropyrane 
• 1210344-25-4 ((3S,4S,5R)-6-allyloxy-3,4,5-tris-benzyloxy-2-hydroxymethyl-tetrahydro-pyran-2-yl)-methanol 

Relevant academic research and scientific papers

DIOXA-BICYCLO[3.2.1.]OCTANE-2,3,4-TRIOL DERIVATIVES

Compounds of Formula (I) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in particular, SGLT2 inhibitors).The compounds disclosed herein are useful for the prevention and treatment of obesity and its associated co-morbidities, inn particular type Il (type 2) diabetes.